about
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudil...
Read More
1.32
0.03
(2.33%)
15,456.4
XNAS Volume
XNAS 30 Jul, 2026 10:00 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Medicinova Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..